BOSTON--(BUSINESS WIRE)--Dr. Mauro Ferrari, the world’s leading cancer nanotechnology authority, has announced the creation of Leonardo BioSystems, Inc., a new company that will focus on nanotechnology-based cancer therapeutics. Toward these ends, Leonardo will integrate Dr. Ferrari’s extensive technology portfolio with the discoveries of many of the premier cancer research institutions.
